购物车
0
有库存
HIT219619352
 sdf 文件
结构编辑
类似物检索
HIT219619352
  • HIT ID:HIT219619352
  • Cas No:1931111-41-9
  • 常用名:PD-L1 inhibitory peptide
  • IUPAC:(2S)-2-(2-{[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-42-(2-aminoethyl)-6-(aminomethyl)-33,36-dibutyl-15-(carbamoylmethyl)-39-{[1-(carboxymethyl)-1H-indol-3-yl]methyl}-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-[(1H-indol-3-yl)methyl]-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecaazatricyclo[46.3.0.0^{9,13}]henpentacontan-27-yl]formamido}acetamido)pent-4-ynoic acid
    IUPAC:(2S)-2-(2-{[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-42-(2-aminoethyl)-6-(aminomethyl)-33,36-dibutyl-15-(carbamoylmethyl)-39-{[1-(carboxymethyl)-1H-indol-3-yl]methyl}-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-[(1H-indol-3-yl)methyl]-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecaazatricyclo[46.3.0.0^{9,13}]henpentacontan-27-yl]formamido}acetamido)pent-4-ynoic acid
  • InChI key:InChIKey=YZIXAMWYVQPTNK-BFHZYFNMSA-N
  • 分子式:C96H135N21O23S
  • 分子量:1983.32
  • 氢键供体数 (HBD):
  • 氢键受体数 (HBA):
  • LogP:
  • SMILES:[H][C@@]12CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc1cn(CC(O)=O)c3ccccc13)NC(=O)[C@H](CCN)NC(=O)[C@H](Cc1c[nH]c3ccccc13)NC(=O)[C@]1([H])C[C@@H](O)CN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CN)NC2=O)C(=O)NCC(=O)N[C@@H](CC#C)C(O)=O
    SMILES:[H][C@@]12CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc1cn(CC(O)=O)c3ccccc13)NC(=O)[C@H](CCN)NC(=O)[C@H](Cc1c[nH]c3ccccc13)NC(=O)[C@]1([H])C[C@@H](O)CN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CN)NC2=O)C(=O)NCC(=O)N[C@@H](CC#C)C(O)=O
  • PD-L1inhibitory peptide是一种靶向程序性细胞死亡配体1 (PD-L1) 的抑制剂肽。它通过结合PD-L1解除免疫抑制,恢复T细胞的抗肿瘤活性, 并有望应用于肿瘤研究。
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    纯度
    -
    待询
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~